Clinical and economic consequences of ventilator-associated pneumonia: a systematic review

N Safdar, C Dezfulian, HR Collard… - Critical care medicine, 2005 - journals.lww.com
Background: Ventilator-associated pneumonia (VAP) is the most common nosocomial
infection in critically ill patients. The clinical and economic consequences of VAP are …

Invasive mould infections in the ICU setting: complexities and solutions

M Bassetti, E Bouza - Journal of Antimicrobial Chemotherapy, 2017 - academic.oup.com
Infections caused by filamentous fungi represent a major burden in the ICU. Invasive
aspergillosis is emerging in non-neutropenic individuals with predisposing conditions, eg …

Invasive aspergillosis in the intensive care unit

W Meersseman, K Lagrou, J Maertens… - Clinical infectious …, 2007 - academic.oup.com
Data regarding the incidence of invasive aspergillosis (IA) in the intensive care unit (ICU)
are scarce, and the incidence varies. An incidence of 5.8% in a medical ICU has been …

Pseudomonas aeruginosa ventilator-associated pneumonia management

S Ramírez-Estrada, B Borgatta… - Infection and drug …, 2016 - Taylor & Francis
Ventilator-associated pneumonia is the most common infection in intensive care unit
patients associated with high morbidity rates and elevated economic costs; Pseudomonas …

Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis

DW Denning, KA Marr, WM Lau, DP Facklam… - Journal of Infection, 2006 - Elsevier
BACKGROUND: Micafungin (FK463) is a new lipopeptide compound (echinocandin) with
activity against Aspergillus and Candida species. This study evaluated the safety and …

Ventilator-associated pneumonia: a review

KA Davis - Journal of Intensive Care Medicine, 2006 - journals.sagepub.com
Ventilator-associated pneumonia is the most frequent intensive care unit (ICU)-related
infection in patients requiring mechanical ventilation. In contrast to other ICU-related …

[HTML][HTML] Hospital acquired pneumonia prevention initiative-2: incidence of nonventilator hospital-acquired pneumonia in the United States

D Baker, B Quinn - American Journal of Infection Control, 2018 - Elsevier
Background Because nonventilator hospital-acquired pneumonia (NV-HAP) is
understudied, our purpose was to determine the incidence, overall burden, and level of …

Prevalence of atypical pathogens in patients with severe pneumonia: a systematic review and meta-analysis

S Wang, J Tang, Y Tan, Z Song, L Qin - BMJ open, 2023 - bmjopen.bmj.com
Objectives We aimed to summarise the prevalence of atypical pathogens in patients with
severe pneumonia to understand the prevalence of severe pneumonia caused by atypical …

Anti-Pseudomonas aeruginosa Vaccines and Therapies: An Assessment of Clinical Trials

MM Elmassry, JA Colmer-Hamood, J Kopel… - Microorganisms, 2023 - mdpi.com
Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen that causes high
morbidity and mortality in cystic fibrosis (CF) and immunocompromised patients, including …

Neumonía nosocomial

E Díaz, I Martín-Loeches, J Vallés - Enfermedades Infecciosas y …, 2013 - Elsevier
The hospital acquired pneumonia (HAP) is one of the most common infections acquired
among hospitalised patients. Within the HAP, the ventilator-associated pneumonia (VAP) is …